NASDAQ:QURE

Uniqure N.v Stock Insider Trading

etoro logo Buy QURE
*Your capital is at risk
$49.04
+4.65 (+10.48%)
At Close: Jun 23, 2026

uniQure N.V Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -78.90. In total, the insiders bought 1.24M and sold 532.98K QURE shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-78.90
Buy 1.24M shares
Sell 532.98K shares
53% Buy Activity
Negligible or No Correlation
Sell Signal Medium Confidence
Jun 17, 2026

Analysis Breakdown:

  • Strongly supported by a very low Insider Power Score of -78.9.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jun 18, 2026
Buy
Ordinary Shares
M-Exempt
Kapusta Matthew C
CEO, Managing Director
CEO / President 4 656
Value: $147.6K
Jun 18, 2026
Sell
Ordinary Shares
S-Sale
Kapusta Matthew C
CEO, Managing Director
CEO / President 4 656
Value: $232.8K
Jun 18, 2026
Sell
Ordinary Shares
S-Sale
Kapusta Matthew C
CEO, Managing Director
CEO / President 37 015
Value: $1.85M
Jun 18, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Kapusta Matthew C
CEO, Managing Director
CEO / President 4 656
Value: $147.6K
Jun 17, 2026
Sell
Ordinary Shares
S-Sale
Kapusta Matthew C
CEO, Managing Director
CEO / President 56 929
Value: $2.47M
Jun 17, 2026
Sell
Ordinary Shares
S-Sale
Kapusta Matthew C
CEO, Managing Director
CEO / President 32 581
Value: $1.47M
Jun 17, 2026
Sell
Ordinary Shares
S-Sale
Kapusta Matthew C
CEO, Managing Director
CEO / President 6 023
Value: $263.2K
Jun 17, 2026
Sell
Ordinary Shares
S-Sale
Kapusta Matthew C
CEO, Managing Director
CEO / President 23 977
Value: $1.02M
Jun 17, 2026
Buy
Ordinary Shares
M-Exempt
Kapusta Matthew C
CEO, Managing Director
CEO / President 62 581
Value: $1.21M
Jun 17, 2026
Sell
Ordinary Shares
S-Sale
Kaye Jack
Director
Director 5 295
Value: $225.4K
Jun 17, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Kaye Jack
Director
Director 5 295
Value: $167.9K
Jun 17, 2026
Sell
Ordinary Shares
S-Sale
Kapusta Matthew C
CEO, Managing Director
CEO / President 33 334
Value: $1.50M
Jun 17, 2026
Sell
Ordinary Shares
S-Sale
Kapusta Matthew C
CEO, Managing Director
CEO / President 11 585
Value: $563.6K
Jun 17, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Kapusta Matthew C
CEO, Managing Director
CEO / President 62 581
Value: $1.21M
Jun 17, 2026
Buy
Ordinary Shares
M-Exempt
Balachandran Madhavan
Director
Director 6 390
Value: $123.9K
Jun 17, 2026
Sell
Ordinary Shares
S-Sale
Balachandran Madhavan
Director
Director 5 295
Value: $249.3K
Jun 17, 2026
Buy
Ordinary Shares
M-Exempt
Balachandran Madhavan
Director
Director 5 295
Value: $167.9K
Jun 17, 2026
Sell
Ordinary Shares
S-Sale
Balachandran Madhavan
Director
Director 4 700
Value: $205.2K
Jun 17, 2026
Sell
Ordinary Shares
S-Sale
Balachandran Madhavan
Director
Director 1 690
Value: $72.0K
Jun 17, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Balachandran Madhavan
Director
Director 5 295
Value: $167.9K
Jun 17, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Balachandran Madhavan
Director
Director 6 390
Value: $123.9K
Jun 17, 2026
Buy
Ordinary Shares
M-Exempt
Kaye Jack
Director
Director 5 295
Value: $167.9K
Jun 15, 2026
Sell
Ordinary Shares
S-Sale
Potts Jeannette
Chief Legal Officer
Officer 5 237
Value: $144.9K
Jun 15, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Balachandran Madhavan
Director
Director 10 000
Value: $84.9K
Jun 15, 2026
Sell
Ordinary Shares
S-Sale
Balachandran Madhavan
Director
Director 10 000
Value: $278.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT UNIQURE N.V.
uniQure N.V
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phas...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
20.46% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
OSW
$24.00
17.08% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE